Dual Specific Phosphatase 14 Deletion Rescues Retinal Ganglion Cells and Optic Nerve Axons after Experimental Anterior Ischemic Optic Neuropathy

References

• Hayreh SS. Anterior ischaemic optic neuropathy. Iii. Treatment, prophylaxis, and differential diagnosis. Br J Ophthalmol. 1974;58(12):981–89. doi:10.1136/bjo.58.12.981.
   PubMed Web of Science ®Google Scholar
• Hayreh SS. Ischemic optic neuropathy. Prog Retin Eye Res. 2009;28(1):34–62. doi:10.1016/j.preteyeres.2008.11.002.
   PubMed Web of Science ®Google Scholar
• Arnold AC. Pathogenesis of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 2003;23(2):157–63. doi:10.1097/00041327-200306000-00012.
   PubMed Web of Science ®Google Scholar
• Biousse V, Newman NJ. Ischemic optic neuropathies. N Engl J Med. 2015;373:1677.
   PubMed Web of Science ®Google Scholar
• Beri M, Klugman MR, Kohler JA, Hayreh SS. Anterior ischemic optic neuropathy. Vii. Incidence of bilaterality and various influencing factors. Ophthalmology. 1987;94(8):1020–28. doi:10.1016/S0161-6420(87)33350-0.
   PubMed Web of Science ®Google Scholar
• Slater BJ, Mehrabian Z, Guo Y, Hunter A, Bernstein SL. Rodent anterior ischemic optic neuropathy (raion) induces regional retinal ganglion cell apoptosis with a unique temporal pattern. Invest Ophthalmol Vis Sci. 2008;49(8):3671–76. doi:10.1167/iovs.07-0504.
   PubMed Web of Science ®Google Scholar
• Zhang C, Guo Y, Slater BJ, Miller NR, Bernstein SL. Axonal degeneration, regeneration and ganglion cell death in a rodent model of anterior ischemic optic neuropathy (raion). Exp Eye Res. 2010;91(2):286–92. doi:10.1016/j.exer.2010.05.021.
   PubMed Web of Science ®Google Scholar
• Ho JK, Stanford MP, Shariati MA, Dalal R, Liao YJ. Optical coherence tomography study of experimental anterior ischemic optic neuropathy and histologic confirmation. Invest Ophthalmol Vis Sci. 2013;54(9):5981–88. doi:10.1167/iovs.13-12419.
   PubMed Web of Science ®Google Scholar
• Slater BJ, Vilson FL, Guo Y, Weinreich D, Hwang S, Bernstein SL. Optic nerve inflammation and demyelination in a rodent model of nonarteritic anterior ischemic optic neuropathy. Invest Ophthalmol Vis Sci. 2013;54(13):7952–61. doi:10.1167/iovs.13-12064.
   PubMed Web of Science ®Google Scholar
• Levin LA, Danesh-Meyer HV. Hypothesis: A venous etiology for nonarteritic anterior ischemic optic neuropathy. Arch Ophthalmol. 2008;126(11):1582–85. doi:10.1001/archopht.126.11.1582.
   PubMedGoogle Scholar
• Zhou Y, Pernet V, Hauswirth WW, Di Polo A. Activation of the extracellular signal-regulated kinase 1/2 pathway by aav gene transfer protects retinal ganglion cells in glaucoma. Mol Ther. 2005;12(3):402–12. doi:10.1016/j.ymthe.2005.04.004.
   PubMed Web of Science ®Google Scholar
• Fujita Y, Sato A, Yamashita T. Brimonidine promotes axon growth after optic nerve injury through erk phosphorylation. Cell Death Dis. 2013;4(e763). doi:10.1038/cddis.2013.298.
   Web of Science ®Google Scholar
• Roth S, Shaikh AR, Hennelly MM, Li Q, Bindokas V, Graham CE. Mitogen-activated protein kinases and retinal ischemia. Invest Ophthalmol Vis Sci. 2003;44:5383–95.
   PubMed Web of Science ®Google Scholar
• Sun J, Nan G. The mitogen-activated protein kinase (mapk) signaling pathway as a discovery target in stroke. J Mol Neurosci. 2016;59(1):90–98. doi:10.1007/s12031-016-0717-8.
   PubMed Web of Science ®Google Scholar
• Sawe N, Steinberg G, Zhao H. Dual roles of the mapk/erk1/2 cell signaling pathway after stroke. J Neurosci Res. 2008;86(8):1659–69. doi:10.1002/jnr.21604.
   PubMed Web of Science ®Google Scholar
• Liu Y, Tao L, Fu X, Zhao Y, Xu X. Bdnf protects retinal neurons from hyperglycemia through the trkb/erk/mapk pathway. Mol Med Rep. 2013;7(6):1773–78. doi:10.3892/mmr.2013.1433.
   PubMed Web of Science ®Google Scholar
• Hu Y, Cho S, Goldberg JL. Neurotrophic effect of a novel trkb agonist on retinal ganglion cells. Invest Ophthalmol Vis Sci. 2010;51:1747–54.
   PubMed Web of Science ®Google Scholar
• Almasieh M, Wilson AM, Morquette B, Cueva Vargas JL, Di Polo A. The molecular basis of retinal ganglion cell death in glaucoma. Prog Retin Eye Res. 2012;31(2):152–81. doi:10.1016/j.preteyeres.2011.11.002.
   PubMed Web of Science ®Google Scholar
• Feng L, Chen H, Yi J, Troy JB, Zhang HF, Liu X. Long-term protection of retinal ganglion cells and visual function by brain-derived neurotrophic factor in mice with ocular hypertension. Invest Ophthalmol Vis Sci. 2016;57(8):3793–802. doi:10.1167/iovs.16-19825.
   PubMed Web of Science ®Google Scholar
• Pease ME, Zack DJ, Berlinicke C, Bloom K, Cone F, Wang Y, Klein RL, Hauswirth WW, Quigley HA. Effect of cntf on retinal ganglion cell survival in experimental glaucoma. Invest Ophthalmol Vis Sci. 2009;50(5):2194–200. doi:10.1167/iovs.08-3013.
   PubMed Web of Science ®Google Scholar
• Robinson MJ, Cobb MH. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol. 1997;9(2):180–86. doi:10.1016/S0955-0674(97)80061-0.
   PubMed Web of Science ®Google Scholar
• Tan Z, Chang X, Puga A, Xia Y. Activation of mitogen-activated protein kinases (mapks) by aromatic hydrocarbons: role in the regulation of aryl hydrocarbon receptor (ahr) function. Biochem Pharmacol. 2002;64(5–6):771–80. doi:10.1016/S0006-2952(02)01138-3.
   PubMed Web of Science ®Google Scholar
• Cowan KJ, Storey KB. Mitogen-activated protein kinases: new signaling pathways functioning in cellular responses to environmental stress. J Exp Biol. 2003;206(Pt 7):1107–15. doi:10.1242/jeb.00220.
   PubMed Web of Science ®Google Scholar
• Kim BJ, Silverman SM, Liu Y, Wordinger RJ, Pang IH, Clark AF. In vitro and in vivo neuroprotective effects of cjun n-terminal kinase inhibitors on retinal ganglion cells. Mol Neurodegener. 2016;11(30). doi:10.1186/s13024-016-0093-4.
   Web of Science ®Google Scholar
• Kikuchi M, Tenneti L, Lipton SA. Role of p38 mitogen-activated protein kinase in axotomy-induced apoptosis of rat retinal ganglion cells. J Neurosci. 2000;20(13):5037–44. doi:10.1523/JNEUROSCI.20-13-05037.2000.
   PubMed Web of Science ®Google Scholar
• Kondoh K, Nishida E. Regulation of map kinases by map kinase phosphatases. Biochim Biophys Acta. 2007;1773(8):1227–37. doi:10.1016/j.bbamcr.2006.12.002.
   PubMed Web of Science ®Google Scholar
• Apara A, Galvao J, Wang Y, Blackmore M, Trillo A, Iwao K, Brown DP Jr., Fernandes KA, Huang A, Nguyen T, et al. Klf9 and jnk3 interact to suppress axon regeneration in the adult cns. J Neurosci. 2017;37(40):9632–44. doi:10.1523/JNEUROSCI.0643-16.2017.
   PubMed Web of Science ®Google Scholar
• Galvao J, Iwao K, Apara A, Wang Y, Ashouri M, Shah TN, Blackmore M, Kunzevitzky NJ, Moore DL, Goldberg JL. The kruppel-like factor gene target dusp14 regulates axon growth and regeneration. Invest Ophthalmol Vis Sci. 2018;59(7):2736–47. doi:10.1167/iovs.17-23319.
   PubMed Web of Science ®Google Scholar
• Moore DL, Blackmore MG, Hu Y, Kaestner KH, Bixby JL, Lemmon VP, Goldberg JL. Klf family members regulate intrinsic axon regeneration ability. Science. 2009;326(5950):298–301. doi:10.1126/science.1175737.
   PubMed Web of Science ®Google Scholar
• Yang CY, Li JP, Chiu LL, Lan JL, Chen DY, Chuang HC, Huang CY, Tan TH. Dual-specificity phosphatase 14 (dusp14/mkp6) negatively regulates tcr signaling by inhibiting tab1 activation. J Immunol. 2014;192(4):1547–57. doi:10.4049/jimmunol.1300989.
   PubMed Web of Science ®Google Scholar
• Yu C, Ho JK, Liao YJ. Subretinal fluid is common in experimental non-arteritic anterior ischemic optic neuropathy. Eye (Lond). 2014;28(12):1494–501. doi:10.1038/eye.2014.220.
   PubMed Web of Science ®Google Scholar
• Shariati MA, Park JH, Liao YJ. Optical coherence tomography study of retinal changes in normal aging and after ischemia. Invest Ophthalmol Vis Sci. 2015;56(5):2790–97. doi:10.1167/iovs.14-15145.
   PubMed Web of Science ®Google Scholar
• Bernstein SL, Guo Y, Kelman SE, Flower RW, Johnson MA. Functional and cellular responses in a novel rodent model of anterior ischemic optic neuropathy. Invest Ophthalmol Vis Sci. 2003;44(10):4153–62. doi:10.1167/iovs.03-0274.
   PubMed Web of Science ®Google Scholar
• Goldenberg-Cohen N, Guo Y, Margolis F, Cohen Y, Miller NR, Bernstein SL. Oligodendrocyte dysfunction after induction of experimental anterior optic nerve ischemia. Invest Ophthalmol Vis Sci. 2005;46(8):2716–25. doi:10.1167/iovs.04-0547.
   PubMed Web of Science ®Google Scholar
• Kumar V, Mesentier-Louro LA, Oh AJ, Heng K, Shariati MA, Huang H, Hu Y, Liao YJ. Increased er stress after experimental ischemic optic neuropathy and improved rgc and oligodendrocyte survival after treatment with chemical chaperon. Invest Ophthalmol Vis Sci. 2019;60(6):1953–66. doi:10.1167/iovs.18-24890.
   PubMed Web of Science ®Google Scholar
• Nakano N, Ikeda HO, Hangai M, Muraoka Y, Toda Y, Kakizuka A, Yoshimura N. Longitudinal and simultaneous imaging of retinal ganglion cells and inner retinal layers in a mouse model of glaucoma induced by n-methyl-d-aspartate. Invest Ophthalmol Vis Sci. 2011;52(12):8754–62. doi:10.1167/iovs.10-6654.
   PubMed Web of Science ®Google Scholar
• Hein K, Gadjanski I, Kretzschmar B, Lange K, Diem R, Sattler MB, Bahr M. An optical coherence tomography study on degeneration of retinal nerve fiber layer in rats with autoimmune optic neuritis. Invest Ophthalmol Vis Sci. 2012;53(1):157–63. doi:10.1167/iovs.11-8092.
   PubMed Web of Science ®Google Scholar
• Huang H, Miao L, Liang F, Liu X, Xu L, Teng X, Wang Q, Ridder WH 3rd, Shindler KS, Sun Y, et al. Neuroprotection by eif2alpha-chop inhibition and xbp-1 activation in eae/optic neuritiss. Cell Death Dis. 2017;8(7):e2936. doi:10.1038/cddis.2017.329.
   PubMed Web of Science ®Google Scholar
• Mammone T, Chidlow G, Casson RJ, Wood JPM. Expression and activation of mitogen-activated protein kinases in the optic nerve head in a rat model of ocular hypertension. Mol Cell Neurosci. 2018;88(270–291). doi:10.1016/j.mcn.2018.01.002.
   PubMed Web of Science ®Google Scholar
• Hollander A, D’Onofrio PM, Magharious MM, Lysko MD, Koeberle PD. Quantitative retinal protein analysis after optic nerve transection reveals a neuroprotective role for hepatoma-derived growth factor on injured retinal ganglion cells. Invest Ophthalmol Vis Sci. 2012;53(7):3973–89. doi:10.1167/iovs.11-8350.
   PubMed Web of Science ®Google Scholar
• Lawan A, Al-Harthi S, Cadalbert L, McCluskey AG, Shweash M, Grassia G, Grant A, Boyd M, Currie S, Plevin R. Deletion of the dual specific phosphatase-4 (dusp-4) gene reveals an essential non-redundant role for map kinase phosphatase-2 (mkp-2) in proliferation and cell survival. J Biol Chem. 2011;286(15):12933–43. doi:10.1074/jbc.M110.181370.
   PubMed Web of Science ®Google Scholar
• Vandereyken MM, Singh P, Wathieu CP, Jacques S, Zurashvilli T, Dejager L, Amand M, Musumeci L, Singh M, Moutschen MP, et al. Dual-specificity phosphatase 3 deletion protects female, but not male, mice from endotoxemia-induced and polymicrobial-induced septic shock. J Immunol. 2017;199(7):2515–27. doi:10.4049/jimmunol.1602092.
   PubMed Web of Science ®Google Scholar
• Vattakuzhi Y, Abraham SM, Freidin A, Clark AR, Horwood NJ. Dual-specificity phosphatase 1-null mice exhibit spontaneous osteolytic disease and enhanced inflammatory osteolysis in experimental arthritis. Arthritis Rheum. 2012;64(7):2201–10. doi:10.1002/art.34403.
   PubMed Web of Science ®Google Scholar
• Maillet M, Purcell NH, Sargent MA, York AJ, Bueno OF, Molkentin JD. Dusp6 (mkp3) null mice show enhanced erk1/2 phosphorylation at baseline and increased myocyte proliferation in the heart affecting disease susceptibility. J Biol Chem. 2008;283(45):31246–55. doi:10.1074/jbc.M806085200.
   PubMed Web of Science ®Google Scholar
• Dreixler JC, Bratton A, Du E, Shaikh AR, Savoie B, Alexander M, Marcet MM, Roth S. Mitogen-activated protein kinase phosphatase-1 (mkp-1) in retinal ischemic preconditioning. Exp Eye Res. 2011;93(4):340–49. doi:10.1016/j.exer.2010.10.011.
   PubMed Web of Science ®Google Scholar
• Hetman M, Kanning K, Cavanaugh JE, Xia Z. Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. J Biol Chem. 1999;274(32):22569–80. doi:10.1074/jbc.274.32.22569.
   PubMed Web of Science ®Google Scholar
• Sun X, Zhou H, Luo X, Li S, Yu D, Hua J, Mu D, Mao M. Neuroprotection of brain-derived neurotrophic factor against hypoxic injury in vitro requires activation of extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. Int J Dev Neurosci. 2008;26(3–4):363–70. doi:10.1016/j.ijdevneu.2007.11.005.
   PubMed Web of Science ®Google Scholar
• Wu H, Yang SF, Dai J, Qiu YM, Miao YF, Zhang XH. Combination of early and delayed ischemic postconditioning enhances brain-derived neurotrophic factor production by upregulating the erk-creb pathway in rats with focal ischemia. Mol Med Rep. 2015;12(5):6427–34. doi:10.3892/mmr.2015.4327.
   PubMed Web of Science ®Google Scholar